306 related articles for article (PubMed ID: 33391269)
1. Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue.
Upasani V; Scagnolari C; Frasca F; Smith N; Bondet V; Vanderlinden A; Lay S; Auerswald H; Heng S; Laurent D; Ly S; Duong V; Antonelli G; Dussart P; Duffy D; Cantaert T
Front Immunol; 2020; 11():605087. PubMed ID: 33391269
[TBL] [Abstract][Full Text] [Related]
2. Characterization of type I interferon responses in dengue and severe dengue in children in Paraguay.
Talarico LB; Byrne AB; Amarilla S; Lovera D; Vázquez C; Chamorro G; Acosta PL; Ferretti A; Caballero MT; Arbo A; Polack FP
J Clin Virol; 2017 Dec; 97():10-17. PubMed ID: 29078078
[TBL] [Abstract][Full Text] [Related]
3. Plasmacytoid dendritic cells control dengue and Chikungunya virus infections via IRF7-regulated interferon responses.
Webster B; Werneke SW; Zafirova B; This S; Coléon S; Décembre E; Paidassi H; Bouvier I; Joubert PE; Duffy D; Walzer T; Albert ML; Dreux M
Elife; 2018 Jun; 7():. PubMed ID: 29914621
[TBL] [Abstract][Full Text] [Related]
4. STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor.
Perry ST; Buck MD; Lada SM; Schindler C; Shresta S
PLoS Pathog; 2011 Feb; 7(2):e1001297. PubMed ID: 21379341
[TBL] [Abstract][Full Text] [Related]
5. A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity.
Pichyangkul S; Endy TP; Kalayanarooj S; Nisalak A; Yongvanitchit K; Green S; Rothman AL; Ennis FA; Libraty DH
J Immunol; 2003 Nov; 171(10):5571-8. PubMed ID: 14607965
[TBL] [Abstract][Full Text] [Related]
6. Innate immunity evasion by Dengue virus.
Morrison J; Aguirre S; Fernandez-Sesma A
Viruses; 2012 Mar; 4(3):397-413. PubMed ID: 22590678
[TBL] [Abstract][Full Text] [Related]
7. Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
Züst R; Toh YX; Valdés I; Cerny D; Heinrich J; Hermida L; Marcos E; Guillén G; Kalinke U; Shi PY; Fink K
J Virol; 2014 Jul; 88(13):7276-85. PubMed ID: 24741106
[TBL] [Abstract][Full Text] [Related]
8. Dengue virus infection induces interferon-lambda1 to facilitate cell migration.
Hsu YL; Wang MY; Ho LJ; Lai JH
Sci Rep; 2016 Jul; 6():24530. PubMed ID: 27456172
[TBL] [Abstract][Full Text] [Related]
9. Early dengue virus interactions: the role of dendritic cells during infection.
Santos Souza HF; da Silva Almeida B; Boscardin SB
Virus Res; 2016 Sep; 223():88-98. PubMed ID: 27381061
[TBL] [Abstract][Full Text] [Related]
10. Sequential waves of gene expression in patients with clinically defined dengue illnesses reveal subtle disease phases and predict disease severity.
Sun P; García J; Comach G; Vahey MT; Wang Z; Forshey BM; Morrison AC; Sierra G; Bazan I; Rocha C; Vilcarromero S; Blair PJ; Scott TW; Camacho DE; Ockenhouse CF; Halsey ES; Kochel TJ
PLoS Negl Trop Dis; 2013; 7(7):e2298. PubMed ID: 23875036
[TBL] [Abstract][Full Text] [Related]
11. Temporal dynamics of the transcriptional response to dengue virus infection in Nicaraguan children.
Popper SJ; Gordon A; Liu M; Balmaseda A; Harris E; Relman DA
PLoS Negl Trop Dis; 2012; 6(12):e1966. PubMed ID: 23285306
[TBL] [Abstract][Full Text] [Related]
12. Identification of changes in dendritic cell subsets that correlate with disease severity in dengue infection.
Lertjuthaporn S; Khowawisetsut L; Keawvichit R; Polsrila K; Chuansumrit A; Chokephaibulkit K; Thitilertdecha P; Onlamoon N; Ansari AA; Pattanapanyasat K
PLoS One; 2018; 13(7):e0200564. PubMed ID: 30001408
[TBL] [Abstract][Full Text] [Related]
13. Dengue Virus-Infected Dendritic Cells, but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules.
Costa VV; Ye W; Chen Q; Teixeira MM; Preiser P; Ooi EE; Chen J
mBio; 2017 Aug; 8(4):. PubMed ID: 28765218
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex.
Rodriguez-Madoz JR; Belicha-Villanueva A; Bernal-Rubio D; Ashour J; Ayllon J; Fernandez-Sesma A
J Virol; 2010 Oct; 84(19):9760-74. PubMed ID: 20660196
[TBL] [Abstract][Full Text] [Related]
15. Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.
He Z; Zhu X; Wen W; Yuan J; Hu Y; Chen J; An S; Dong X; Lin C; Yu J; Wu J; Yang Y; Cai J; Li J; Li M
J Virol; 2016 Aug; 90(16):7219-7230. PubMed ID: 27252539
[TBL] [Abstract][Full Text] [Related]
16. Administration of plasmacytoid dendritic cell-stimulative lactic acid bacteria is effective against dengue virus infection in mice.
Suzuki H; Tsuji R; Sugamata M; Yamamoto N; Yamamoto N; Kanauchi O
Int J Mol Med; 2019 Jan; 43(1):426-434. PubMed ID: 30365042
[TBL] [Abstract][Full Text] [Related]
17. Increased activity of indoleamine 2,3-dioxygenase in serum from acutely infected dengue patients linked to gamma interferon antiviral function.
Becerra A; Warke RV; Xhaja K; Evans B; Evans J; Martin K; de Bosch N; Rothman AL; Bosch I
J Gen Virol; 2009 Apr; 90(Pt 4):810-817. PubMed ID: 19264674
[TBL] [Abstract][Full Text] [Related]
18. Dengue virus activates membrane TRAIL relocalization and IFN-α production by human plasmacytoid dendritic cells in vitro and in vivo.
Gandini M; Gras C; Azeredo EL; Pinto LM; Smith N; Despres P; da Cunha RV; de Souza LJ; Kubelka CF; Herbeuval JP
PLoS Negl Trop Dis; 2013; 7(6):e2257. PubMed ID: 23755314
[TBL] [Abstract][Full Text] [Related]
19. How Dengue Virus Circumvents Innate Immunity.
Kao YT; Lai MMC; Yu CY
Front Immunol; 2018; 9():2860. PubMed ID: 30564245
[TBL] [Abstract][Full Text] [Related]
20. Differential clinical symptoms among acute phase Indian patients revealed significant association with dengue viral load and serum IFN-gamma level.
Pal T; Dutta SK; Mandal S; Saha B; Tripathi A
J Clin Virol; 2014 Nov; 61(3):365-70. PubMed ID: 25288310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
